Your browser doesn't support javascript.
loading
Advantages and applications of CAR-expressing natural killer cells.
Glienke, Wolfgang; Esser, Ruth; Priesner, Christoph; Suerth, Julia D; Schambach, Axel; Wels, Winfried S; Grez, Manuel; Kloess, Stephan; Arseniev, Lubomir; Koehl, Ulrike.
Afiliación
  • Glienke W; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
  • Esser R; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
  • Priesner C; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
  • Suerth JD; Institute of Experimental Hematology, Hannover Medical School Hannover, Germany.
  • Schambach A; Institute of Experimental Hematology, Hannover Medical School Hannover, Germany.
  • Wels WS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy Frankfurt am Main, Germany.
  • Grez M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy Frankfurt am Main, Germany.
  • Kloess S; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
  • Arseniev L; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
  • Koehl U; Institute of Cellular Therapeutics Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Germany.
Front Pharmacol ; 6: 21, 2015.
Article en En | MEDLINE | ID: mdl-25729364
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2015 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2015 Tipo del documento: Article País de afiliación: Alemania